AI assistant
PIRAMAL PHARMA LIMITED — Call Transcript 2024
Oct 24, 2024
59525_rns_2024-10-24_f8ddc27f-6edd-47f9-89b1-c5a5cdf46519.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [145 x 60] intentionally omitted <==
24[th] October, 2024
BSE Limited P.J. Towers, Dalal Street, Fort, Mumbai- 400 001 BSE scrip code: 543635
National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex, Bandra (East), Mumbai – 400 051 NSE symbol: PPLPHARMA
Sub: Audio Recording of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30[th] September, 2024
Dear Sir / Madam,
In continuation of our letter dated 14[th] October, 2024 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the conference call held on 24[th] October, 2024 on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended 30[th] September, 2024 is available on the Company’s website at - https://www.piramalpharma.com/financial reports
Kindly take the above on record.
Thanking you,
Yours truly,
For Piramal Pharma Limited
Digitally signed TANYA by TANYA SANISH Date: 2024.10.24 SANISH 18:21:40 +05'30' Tanya Sanish Company Secretary
Piramal Pharma Limited
CIN: L24297MH2020PLC338592 Registered Office: Gr. Flr. Piramal Ananta, Agastya Corporate Park, Opp Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070 India T: +91 22 3802 3000 / 4000; Email : [email protected]
piramalpharma.com